Current Applications for Overcoming Resistance to Targeted Therapies edited by Myron R. Szewczuk, Bessi Qorri, Manpreet Sambi.
Targeted therapies were initially developed to exploit the upregulation and dependence on key oncogenic pathways critical to cancer progression. Additionally, they also presented as a method to overcome chemoresistance by supplementing conventional therapeutic regimens with targeted therapies. Howev...
Full description
Saved in: